In the context of ADs, 2015 was the first time that the oral administration of exosomes isolated from bovine milk had the potential to delay the onset of RA, decreasing cartilage injury, BM inflammation, and the reduction of MCP-1 and IL-6 levels [216]. This evidence concerns the gene IL6 and rheumatoid arthritis.